DF6215, an alpha-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activity. (linkinghub.elsevier.com)

Authors: Stockmann AP … Cheung AF Journal: Cell Reports Medicine Published: 2026-01-20 DOI: https://doi.org/10.1016/j.xcrm.2025.102518